Conference call to take place at 8:30am ET – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2024 financial results before the market opens onMonday, March 17, 2025 via press release, which will be available on the Company's […]

(NYSE:EBS), GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland's next-generation vaccine companies and a member of the Swiss Rockets Ltd family of companies, today announced

(NASDAQ:BNAI), WILMINGTON, Del., March 12, 2025 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, has announced its support for California Assembly Member Carl DeMaio's proposed AI data privacy legislation. This bill, which aims to secure the privacy of California residents, would require businesses to obtain explicit

(NASDAQ:PRTG), DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its

Rising Lifestyle Creator Launches New Educational Video Series Empowers and Inspires the Next Generation of Creators Collective Voice, a leading platform connecting creators and brands through sales-driving social content and monetization opportunities, has announced its new Creator in Residence partnership with lifestyle creator and trusted voice in the community, Chanel Tyler, founder of @buymechanel. https://mma.prnewswire.com/media/2639930/Collective_Voice_Creator_Chanel_Tyler.jpg

Trial Library, a leader in AI-enabled clinical trial matching and patient navigation with a strong reputation in oncology, has partnered with American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, to enhance patient identification and recruitment for oncology clinical trials. The collaboration aims to expand trial access for patients with various cancers,

Enterprises to Balance Cloud-Friendly Solutions with Traditional Hardware as HardwareRecovery Expected in 2025 According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, security, networks, and data center industries, the Network Security market rebounded significantly in 4Q 2024, growing 9 percent year-over-year (Y/Y). For 2024, the market

datma, a leader in federated real-world data access, today announced that its federated real-world data marketplace launched in October of 2024 has surpassed one million records available for research. This milestone demonstrates the strength of datma.FED as a leading platform for secure, federated access to high-quality, demographic, EHR, genomic, and pathology data, providing pharmaceutical and

The Company's New Technology is Designed to Support Overall Space Operations Critical for Consumer Applications and National Defense Quantum Space, a leader in advanced space operations, is launching its life extension services to enhance satellite mission longevity and operational efficiency. Leveraging its highly maneuverable Ranger spacecraft, these services include mission extension, orbital adjustment, and refueling-addressing

Actinium Pharmaceuticals, Inc.(NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it will participate at the 37th Annual Roth Conference on March 16th to 18th. https://mma.prnewswire.com/media/730678/Actinium_Pharmaceuticals_Logo.jpg Actinium management will be in attendance during the conference and will be available for 1-on-1 meetings on March 17th and 18th.